Live news related to IPSEN stock (FR0010259150): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on IPSEN mainly cover M&A activity, analyst notes et share price moves. The stock trades at €160,00 on Euronext Paris, up 0,57% at the last update. This page lists the articles published on IPSEN stock to track the share price, company announcements and any item likely to influence market perception.
The Parisian biopharmaceutical laboratory experienced its worst session of the index on Tuesday morning, driven by a surprise downgrade from Barclays …
The biopharmaceutical laboratory's share is declining sharply at the end of the week, while the SBF 120 remains nearly stable during the session. This…
Ipsen closes a contrasting week on a negative note, while the CAC 40 advances over 1% during the session. The decline of the biopharmaceutical laborat…
The biopharmaceutical laboratory has closed the acquisition of American company Kartos Therapeutics, adding navtemadlin to its portfolio, an experimen…
The biopharmaceutical laboratory stock rebounded during Tuesday's session, advancing among the strongest gains on the SBF 120 index in an almost stabl…
On July 22, 2026, Ipsen announced the completion of its acquisition of Memo Therapeutics AG, a Swiss biotechnology company. This acquisition grants th…
In mid-morning trading in Paris, the biopharmaceutical company continues its decline in a downward-trending Parisian market. The stock is erasing some…
The biopharmaceutical laboratory experiences a sharp decline in the morning, following a major clinical announcement about its botulinum toxin. The st…
On July 9, 2026, Ipsen announced positive Phase III results for Dysport in the prevention of both episodic and chronic migraine, becoming the first la…
The biopharmaceutical company stands out in the late Paris session, continuing an upward trend that started several weeks ago. The stock is testing a …
